Author Archive

Get Your WorldView On: 2015 Scientific American Biotech Scorecard #BIO2015

On Thursday June 18th from 12:30 to 2pm in Room 119B Mike May and I will be going over the seventh edition of Scientific American Worldview. Mike is the editor of Worldview. This is a more intimate session than the Super Session (below), and we will discuss the impetus for developing Worldview as well highlighting […]


Come to my book signing at #BIO2015

I will be signing my textbook Building Biotechnology, and other books, in the BIO bookstore on Thursday June 18th from 10:00 am – 11:30 am. Building Biotechnology is used by dozens of schools, and I am always happy to meet professors, students, and industry professionals who have used the book. Stop by, even if it is just to […]


Kickstarting biotechnology crowdfunding #BIO2015

A quick note from BIO2015. Biotechnology crowdfunding levels pale in comparison to other industries. There are many reasons for this disparity — risk, high capital requirements, and the technical nature of many biotechnology applications. A talk by Wharton”s Steve Sammut, based on research by Roger Younan, revealed that biotechnology applications are absent from the list […]


Yali Friedman named one of the 100 most influential people in biotechnology by Scientific American #BIO2015

Scientific American has released its list of the 100 most influential people in biotechnology. I am honored to be included in this exclusive list and recognized for my thought leadership on the business of biotechnology. For more than a decade I have had the privilege to be an entrepreneur and academic without borders, researching and developing publications in areas […]


Discussing Biotechnology in Emerging Markets at #BIO2015

Join me and an esteemed set of panelists at the opening plenary for the Emerging Opportunities in Global Markets track at BIO2015. I will be participating in a discussion that delves deeply into the policies and factors that foster (or hinder) biotech industry success in markets around the world, where I will be discussing the Scientific American Worldview project. […]


Looking forward to BIO #BIO2015

I am looking forward to this year’s BIO convention, as it returns to Philadelphia. It will be a busy conference. In addition to connecting with colleagues, representing the Journal of Commercial Biotechnology, and this blog, I will also be signing books, giving a talk, and attending the Scientific American Worldview rollout. Highlights: I will be signing […]


Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions

The following paper has been added to the free open access archives at the Journal of Commercial Biotechnology: Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions David Eugene Menshew This paper examines the creation of a forensic biotechnology program that engages students, promotes science learning beyond the […]


DrugPatentWatch adds Supplementary Protection Certificates

DrugPatentWatch has expanded its global coverage of pharmaceutical patents by adding coverage of Supplementary Protection Certificates. DrugPatentWatch provides deep knowledge on pharmaceutical drugs and the 90,000 global patents covering them. Uses cases include: Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate future budget requirements and proactively identify generic sources Branded pharmaceutical manufacturers Assess past successes […]


Journal of Commercial Biotechnology Seeks Managing Editor

The Journal of Commercial Biotechnology is seeking applications for the position of Managing Editor. Responsibilities The Journal of Commercial Biotechnology has been described as “a Harvard Business Review for Biotechnology Companies.” The Managing Editor should seek to maintain this editorial focus and strong standing through: – Solicitation of papers in line with the JCB’s editorial focus – […]


Drug Patent Expirations for Apr 30, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LAMISIL (terbinafine) Novartis Patent number: 5,681,849 Expiration Date: Apr 28, 2015 LAMISIL AT (terbinafine hydrochloride) Novartis Patent number: 5,681,849 Expiration Date: Apr 28, 2015 LAMISIL AT (terbinafine) Novartis […]